These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3229875)

  • 1. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buflomedil for intermittent claudication.
    De Backer TL; Vander Stichele RH; Bogaert MG
    Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
    Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P
    Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supervised exercise training for intermittent claudication: lasting benefit at three years.
    Ratliff DA; Puttick M; Libertiny G; Hicks RC; Earby LE; Richards T
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
    Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
    Clement DL; Duprez D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S89-95. PubMed ID: 2446082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.